Targretin Gel 1% FDA Reviewers
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Targretin Gel 1% FDA Reviewers
|
<table bordercolor="#000000" cellspacing="3" cellpadding="4" width="672" border="1"> <tbody> <tr> <td valign="top" colspan="2"> <br /> <br /> <p> <b><font face="Times" size="5">Targretin Gel 1% FDA Reviewers</font></b> </p> </td> </tr> <tr> <td valign="top" width="31%"> <p> <b><font face="Helvetica Condensed" size="2">Medical</font></b> </p> </td> <td valign="top" width="69%"> <p> <font face="Helvetica Condensed" size="2">Robert White, MD</font> </p> </td> </tr> <tr> <td valign="top" width="31%" bgcolor="#ffffff"> <p> <b><font face="Helvetica Condensed" size="2">Statistics</font></b> </p> </td> <td valign="top" width="69%" bgcolor="#ffffff"> <p> <font face="Helvetica Condensed" size="2">Mark Rothmann, PhD</font> </p> </td> </tr> <tr> <td valign="top" width="31%" bgcolor="#ffffff"> <p> <b><font face="Helvetica Condensed" size="2">Chemistry</font></b> </p> </td> <td valign="top" width="69%" bgcolor="#ffffff"> <p> <font face="Helvetica Condensed" size="2">Sung Kim, PhD</font> </p> </td> </tr> <tr> <td valign="top" width="31%" bgcolor="#ffffff"> <p> <b><font face="Helvetica Condensed" size="2">Biopharmaceutics</font></b> </p> </td> <td valign="top" width="69%" bgcolor="#ffffff"> <p> <font face="Helvetica Condensed" size="2">Gene Williams, PhD</font> </p> </td> </tr> <tr> <td valign="top" width="31%" bgcolor="#ffffff"> <p> <b><font face="Helvetica Condensed" size="2">Pharmacology/Toxicology</font></b> </p> </td> <td valign="top" width="69%" bgcolor="#ffffff"> <p> <font face="Helvetica Condensed" size="2">Chang Ahn, PhD</font> </p> </td> </tr> <tr> <td valign="top" width="31%" bgcolor="#ffffff"> <p> <b><font face="Helvetica Condensed" size="2">Regulatory Health Project Manager</font></b> </p> </td> <td valign="top" width="69%" bgcolor="#ffffff"> <p> <font face="Helvetica Condensed" size="2">Amy Chapman</font> </p> </td> </tr> </tbody> </table> |